跳至主要内容
临床试验/NCT03968211
NCT03968211已完成1 期

Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency

University of Virginia2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2019年7月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
37
试验地点
2
主要终点
Vaccination response

研究概览

简要总结

This study is trying to find out if an undetectable serum immunoglobulin E (IgE) is a biomarker, or early sign of, the development of immune deficiency.

详细描述

IgE is the antibody thought to be responsible for developing allergies. Undetectable serum IgE (an IgE below the lower limit of detection) is found in about 3% of the general population. In the past, it has been thought that having an undetectable IgE does not have any health impact, other than meaning that you are at low risk for having allergies. However, recent studies of patients with undetectable IgE have shown higher rates of infections, autoimmune disease and cancer.

Patients with an immune deficiency called common variable immunodeficiency (CVID) also have higher rates of infections, autoimmune disease and cancer. Recently, we have shown that most patients with CVID have a low/undetectable serum IgE.

This study is trying to find out if an undetectable serum IgE is a biomarker, or early sign of, the development of CVID or other antibody deficiencies

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18-80
  • Willingness and ability to comply with scheduled visits and study procedures
  • Undetectable serum IgE (defined as >2 IU/mL or the lower threshold of detection)
  • Normal or high serum immunoglobulins (within or above laboratory reference range for IgG, IgA, and IgM)
  • patients previously seen at the University of Virginia Asthma, Allergy, and Immunology clinics where undetectable serum IgE was noted
  • Control subjects must have participated in study IRB#14457 (only applicable for healthy controls in epsilon germline transcript portion of the study)

排除标准

  • The following vulnerable populations will be excluded: pregnant women, fetuses, neonates, children, prisoners, cognitively impaired, educational or economically disadvantaged, non-English speaking subjects
  • Known personal history of immunodeficiency
  • Known personal history of recurrent infections
  • Low serum immunoglobulins (below the laboratory reference range for IgG, IgA, or IgM)
  • Recent or current treatment with systemic immunosuppression within the past 30 days

结局指标

主要结局

Vaccination response

时间窗: 4-6 weeks

IgG to Salmonella typhi will be measured, with a normal response calculated as at least a 2-fold increase in IgG titers post-vaccination

次要结局

  • Epsilon germline transcript production(3 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Larry Borish, MD

Professor of Medicine and Microbiology

University of Virginia

研究点 (2)

Loading locations...

相似试验

Undetectable IgE as a Sentinel Biomarker for Humoral... | 临床试验